Modification of the GABA/benzodiazepine receptor with the arginine reagent, 2,3‐butanedione

Open Access
Publisher Website
Google Scholar
Abstract
Treatment of either crude or purified preparations of the γ‐aminobutyrate (GABA)/benzodiazepine receptor complex with arginine‐specific reagents resulted in a time‐ and concentration‐dependent loss of [3H]muscimol binding activity. Following exposure to either 2,3‐butanedione or phenylglyoxal (⩽ 20 mM), [3H]muscimol binding was inhibited by up to 80%. [3H]Flunitrazepam binding was much less sensitive to the effects of the reagents. Scatchard analysis of the binding data indicated that treatment with butanedione resulted in a loss of [3H]muscimol binding sites with little effect on binding affinity. Considerable protection against inactivation was provided by arginine and by the endogenous receptor ligand, GABA. These results indicate that arginine residues play a critical role in maintaining the GABA receptor in a conformation capable of ligand binding, possibly by participating in the binding site through interaction with the carboxylate moiety of GABA.